Mice not normally susceptible to infection with Leptospira interrogans serovar pomona were rendered susceptible to lethal infections by treatment with a single dose of 300 mg of cyclophosphamide (Cy) per kg administered optimally from 4 days before to 1 day after infection. Cy-treated mice with either passively or actively acquired antibody were protected from death. Blood levels of leptospires in infected untreated and in Cy-treated mice remained similar until 2 days after infection, when untreated mice cleared the leptospires. Soon afterwards, opsonizing and agglutinating antibody appeared. Cy-treated mice given spleen cells from other normal or specifically immune mice were protected from infection. An important factor in the natural resistance of mice to leptospiral infection appears to be their capacity to produce circulating antibody within 48 to 72 h. Applications are suggested for this animal model in vaccination and protection studies.
Many publications describe the depletion of the immune capabilities of mice by the alkylating agent cyclophosphamide (Cy) and the resulting effects on the course of various infections. Cy, in appropriate doses, completely inhibited the primary humoral response to a wide range of bacterial (18) , viral (14, 21) , yeast, (5) , and other antigens (7) . It was also well established that Cy selectively affected B-cell-mediated immunity in mice without markedly affecting their ability to mount a cell-mediated immune response (11, 16, 20) . This immune suppression resulted in an increase in susceptibility to those infectious diseases in which production of antibody is important in resistance to, or recovery from, primary infection, such as in mice infected with Histoplasma capsulatum (5), coxsackie B-3 virus (14) , vaccinia virus (21) , influenza virus (9) , Mycoplasma pulmonis (15) , Rickettsia sennetsu (17) , and Pseudomonas aeruginosa (8) .
Our research had two aims. Hamsters or similar animals suitable for infection with leptospires are not available in Australia, and laboratory strains of mice in general are not susceptible to acute leptospiral infections. An animal model suitable for use in protection studies was sought in immunosuppressed mice, in which suppression of antibody response would lead to susceptibility. Second, by using a relatively selective immunosuppressive agent, we hoped to evaluate the role of humoral antibody in the resistance to leptospiral infection found in the normally insusceptible mouse.
MATERIALS AND METHODS
Organisms. Leptospira interrogans serovars pomona and hardjo were isolated from human patients with leptospirosis in Waikato, New Zealand (4), and were serotyped by the WHO Leptospira Reference Laboratory, Brisbane, Australia. An avirulent strain of serovar pomona was obtained from the School of Public Health and Tropical Medicine, Sydney, Australia. The leptospires were routinely cultured in EMJH medium (Difco Laboratories) and were counted in a Petroff-Hausser bacterial counting chamber. Kidney and liver cultures from infected animals were taken by inoculating into EMJH medium a sample of the organ obtained by stabbing with a sterile Pasteur pipette. For injection into rabbits, the leptospires were maintained in Korthof medium containing 10% rabbit serum (1). Leptospires were heat killed by being held at 56°C for 30 min. Culture supernatant was prepared by centrifuging leptospiral cultures at 12,000 x g for 30 min and then passing the supernatant three times through an 0.22-,um membrane filter (Millipore Corp.). To prepare a boiled leptospiral vaccine, the leptospires were centrifuged at 12,000 x g, washed four times in 0.85% saline, held at 100°C for 2 h, washed four times in saline, and then resuspended in saline to a concentration of 4 x 109/ml.
Mice. An inbred strain of BALB/c mice was used throughout. Mice were infected intraperitoneally with 1 When transferred into irradiated recipients, these cells gave rise to normal numbers of antibody-forming cells.
Spleen cell suspensions were depleted of T-cells by incubation at 37'C with a final 1:8 dilution of anti-theta for 30 min; they were then washed twice in M199 and incubated for 30 min with a 1:6 dilution of normal guinea pig serum absorbed with sheep erythrocytes and agarose. After further washing in M199, the cells were resuspended to the density of 1 spleen equivalent per ml. Each mouse received 1.0 ml injected intraperitoneally. The percentage of dead (theta-bearing) cells in the spleen suspension after treatment was 22%, agreeing with the findings of Poulter and Turk (13) .
RESULTS
Lethality of Cy and inhibition of antibody synthesis. Mice survived single injections of up to 400 mg of Cy per kg. The potency of Cy in inhibiting antibody synthesis was found to vary in different batches. In a typical experiment, mice were immunized with 0.5 ml of a 30% suspension of sheep erythrocytes 48 h after receiving a Cy injection and were bled 10 days later. Hemagglutinin synthesis was completely inhibited by 200 mg of Cy per kg, with 50% suppression at a dose of 50 or 100 mg/kg. A dose of less than 50 mg/kg produced no suppression. In other batches, up to 300 mg of Cy per kg was required to completely suppress hemagglutinin synthesis. To show the suppression of specific antileptospiral antibody, mice were immunized with either 2 x 108 heat-killed serovar pomona or 2 x 108 live avirulent serovar pomona 48 h after an injection of 300 mg of Cy per kg. Neither group had produced any agglutinating antibody 10 days later. The pooled sera of control mice had titers of 16 and 128, respectively.
Infection with serovar pomona in Cytreated mice. Leptospires of serovar pomona, when injected intraperitoneally into normal mice in doses of up to 1010 organisms, failed to produce clinical signs of illness or to kill the mice. A similar injection in mice treated with a single dose of 300 mg of Cy per kg caused typical acute leptospirosis with severe jaundice, renal insufficiency, and death in 4 to 8 days. Findings at autopsy were typical and similar to those in hamsters and very young guinea pigs infected with serovar pomona or icterohaemorrhagiae, with severe hemorrhages, jaundice, and large numbers of leptospires in blood, liver, and kidneys.
The enhancing effect of Cy on infection was time dependent (Fig. 1) . Cy was thereafter routinely administered 48 h before infection, leading to a mortality rate of 90 to 100% after infection with doses of 2 x 108 leptospires. However, mortality rates of over 80% were obtained when This strain could not kill hamsters but was capable of causing the renal carrier state to develop. To examine whether any extracellular leptospiral product could reproduce the lethal effect, Cy-treated mice were injected with culture supernatant ofpomona corresponding to 2 x 108 leptospires. No effect was observed. Heatkilled leptospires had no effect on Cy-treated mice.
Blood levels of leptospires. Leptospires were counted in the blood of infected mice either pretreated with Cy or not (Fig. 2) . Leptospires remained in the blood of Cy-treated mice until death. Numbers of circulating leptospires similar to those found in Cy-treated mice were found in untreated mice until day 2 or 3, when they were rapidly cleared so that no leptospires were detectable by day 4. Liver and kidney cultures in untreated infected mice were negative by day 5 or 6. Agglutinating antibody was detected by MAT in untreated infected mice on day 4 after infection ( Fig. 2) .
Effects of preexisting antibody. A level of circulating antileptospiral antibody was pro- 10 normal infected and Cy-treated infected mice, and MAT antibody response in the untreated infected mice. In this experiment, 9 out of 10 mice died on day 5 . Symbols: (----0) Blood count, untreated infected mice; (0 *) blood count, Cy-treated infected mice; (v-----) MAT titer, infected mice. Cy dose, 300 mg/kg; infecting dose, 2 x 108 serovar pomona.
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Passively administered rabbit antiserum (MAT titer, 512) protected against 3 x 108 to 5 x 108 leptospires when given at any time up to 3 days after infection. A serum MAT titer of 1:4 protected six out of eight mice.
No leptospires were detected in blood taken 2 h after infection of Cy-treated mice that had recovered from previous infection. By contrast, leptospires were found in the blood in other experiments as soon as 1 h after infection in Cytreated or untreated nonimmune mice.
Investigations of antibody produced in the fi'rst 72 h. To investigate the presence of antibody during the 4 days after infection during which leptospires were cleared and before agglutinating antibody was detectable, we looked for the appearance of opsonizing antibody by examining the clearance of 32P-labeled leptospires from the blood streams of normal mice, immune mice, and mice previously infected at various times. The results (Table 3) showed that opsonizing antibody could be detected by this method as early as day 3 after infection.
To investigate the rate of appearance of passively protective antibody, a group of 20 mice was infected with 2 x 108 leptospires; the mice were bled 1, 2, 3, 4, and 5 days after infection, and the sera from each day were pooled. A volume of pooled serum was injected intraperitoneally into groups of Cy-treated infected mice. A 0.2-ml amount of serum from day 4 and onwards completely protected Cy-treated mice from lethal infection. A 0.1-ml amount of serum taken 4 days after infection protected two out of five Cy-treated infected mice. Serum taken 3 days after infection had no protective capacity. Antibody titers were not measured in this experiment. Passive transfer of spleen cells. Cy-treated mice that received approximately 2 x 108 either immune or normal spleen cells were protected from lethal infection (Table 4) . Both groups produced antibody after infection. Recipients of immune spleen cells responded more rapidly, and to a much higher titer, than untreated infected mice, typical of an anamnestic or secondary response (Fig. 3) .
To ascertain the relative importance of Tlymphocytes in the protection transferred by splenocytes, spleen cell suspensions were pretreated with anti-theta before transfer into Cytreated recipients. Despite depletion of T-cells, the spleen suspension was still capable of protecting Cy-treated recipients (Table 4) . Recipients of anti-theta-treated cells were capable of producing agglutinating antibody (Fig. 3) .
DISCUSSION
The ability of immunosuppressive procedures to increase the severity of infectious diseases has been reported for a number of experimental models (see introduction). In the present study, we have demonstrated that the susceptibility of adult mice to leptospiral infection can be greatly increased by administration of a single dose of Cy. Mortality of the immunosuppressed mice was associated with persistent leptospiremia and autopsy findings that indicated severe hepatic and renal dysfunction.
Previous workers have administered Cy at various times before and after infection to obtain enhancement of infection (2, 5, 14, 15, 17, 21) , but in only one of these studies was a timedependence experiment performed (14) . In the- (---) Cy-treated immune spleen cell recipients; (---) Cy-treated normal spleen cell recipients; (----) Cy-treated normal T-cell-depleted spleen cell recipients.
ory, optimum enhancement would be expected when Cy is given after antigenic stimulation during the time when rapid cell division is taking place, but we found any time from 4 days before infection to 1 day after infection to be satisfactory. Similarly, Turk et al. (19) showed impaired B-cell function in guinea pigs treated with Cy 3 days before antigenic stimulation. Working with a coxsackie B-3 virus model, Rager-Zisman and Allison (14) found optimum enhancement of infectivity at 72 h after infection. In our model, however, we found that Cy was effective if administered no later than 24 h after infection.
Antibody was detected by agglutination and passive protective capacity 4 days after infection and by opsonic activity 3 days after infection. Since the first traces of antibody were detected 72 h after infection, nondividing antibody-forming cells are present presumably as early as 24 to 48 h after infection. This would explain why leptospires are cleared from blood at 48 to 72 h and why Cy administered later than 24 h after infection was ineffective.
The effectiveness of Cy given 48 h before infection discounts the possibility that the enhancement of infection is due to pharmacological effects of Cy other than immunosuppression, since Kline et al. (12) showed Cy to have a half-life of only 17 min in mice. The fact that passively administered antibody could reverse the effect of Cy indicates that the drug's B-cellselective immunosuppressive activity was responsible for enhancement. Since culture supernatant did not have any effect on Cy-treated mice in these experiments, the lethality of the leptospires cannot be attributed to any extracellular toxin or other product. Neither can it be attributed to endotoxin-like activity, since heat-killed leptospires had no effect on Cytreated mice. Serovar hardjo, which is capable of infecting humans and establishing kidney infections in hamsters, did not cause acute infections in Cy-treated mice. Obviously the ability of the host to produce antibody cannot be regarded as the sole factor determining the clinical outcome of infection with leptospires.
Cy-treated mice that had preexisting specific antibody were capable of rapidly clearing blood leptospires similarly to untreated immune mice. The drug therefore appears not to have significantly affected the phagocytic capabilities of the mice.
The clearance of blood leptospires by infected mice 48 to 72 h after infection is closely followed by appearance of opsonizing and agglutinating antibody. The opsonic antibody probably reflects the early production of agglutinins in subagglutinating concentrations. In a similar finding, Canonico et al. (3) detected opsonizing antibodies to Francisella tularensis in monkeys 3 days after vaccination.
The evidence therefore suggests that a major factor in the natural resistance of BALB/c mice to infection with serovar pomona is their capability to produce circulating antibody as early as 2 days after infection. Cell-mediated immunity does not appear to be important, since Poulter and Turk (13) showed a proportional increase of theta-bearing lymphocytes in the spleens and lymph nodes of mice treated with 300 mg of Cy per kg. Turk et al. (19) found an intensification of contact reactivity to 2,4,-dinitrofluorobenzene in guinea pigs that had received 300 mg of Cy per kg 3 days previously. Similarly, in experiments to be published separately, we demonstrated a delayed-type hypersensitivity response to tuberculin as measured by footpad swelling in Cy-treated BALB/c mice that were previously immunized with BCG. The evidence for a critical role played by circulating antibody is also supported by the finding VOL. 14, 1976 on November 2, 2017 by guest http://iai.asm.org/ that protection was conferred and antibody was produced after transfer of a spleen cell population depleted of T-lymphocytes.
Endowing Cy-treated mice with the ability to produce antibody through the adoptive transfer of either immune or normal spleen cells other than T-cells appears to be sufficient to enable them to resist infection. The possibility that cell-mediated mechanisms as well as antibody are involved in the immunity that results from previous infection is not excluded by our results.
Our findings with actively vaccinated mice present two further important facts. First, the Cy-treated mouse model is suitable for use in both passive and active protection studies. Second, a heat-stable antigen of serovarpomona is capable of conferring immunity. This aspect is currently being further investigated.
